Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Paoletti

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Computer Methods and Programs in Biomedicine|August 28, 2007
np1: a computer program for dose escalation strategies in phase I clinical trialsAndrew Kramar, Nadine Houédé, Xavier Paoletti
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2017
Dose-Finding Methods: Moving Away from the 3 + 3 to Include Richer OutcomesXavier Paoletti, Damien Drubay, Laurence Collette
Contemporary Clinical Trials Communications|February 15, 2020
Proportional odds assumption for modeling longitudinal ordinal multiple toxicity outcomes in dose finding studies of targeted agents: A pooled analysis of 54 studiesDamien Drubay, Laurence Collette, Xavier Paoletti
Biostatistics (Oxford, England)|August 31, 2018
A benchmark for dose finding studies with continuous outcomesPavel Mozgunov, Thomas Jaki, Xavier Paoletti
Epidemiology (Cambridge, Mass.)|February 5, 2011
Sensitivity analysis when data are missing not-at-randomNoémie Resseguier, Roch Giorgi, Xavier Paoletti
Bulletin Du Cancer|August 7, 2016
[Not Available]Xavier Paoletti, Federico Rotolo, Stefan Michiels
Biometrical Journal. Biometrische Zeitschrift|June 13, 2020
Using a dose-finding benchmark to quantify the loss incurred by dichotomization in Phase II dose-ranging studiesPavel Mozgunov, Thomas Jaki, Xavier Paoletti
Biostatistics (Oxford, England)|August 23, 2003
Non-parametric optimal design in dose finding studiesJohn O'Quigley, Xavier Paoletti, Jean Maccario
Frontiers in Psychiatry|August 16, 2021
Reading, Conducting, and Developing Systematic Review and Individual Patient Data Meta-Analyses in Psychiatry for Treatment IssuesNadia Younes, Laurie-Anne Claude, Xavier Paoletti
European Journal of Cancer (Oxford, England : 1990)|November 21, 2018
Meta-analysis of prognostic and predictive factors: Towards individual participant data?Matthieu Faron, Jean-Pierre Pignon, Xavier Paoletti
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Computer Methods and Programs in Biomedicine|August 28, 2007
np1: a computer program for dose escalation strategies in phase I clinical trialsAndrew Kramar, Nadine Houédé, Xavier Paoletti
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2017
Dose-Finding Methods: Moving Away from the 3 + 3 to Include Richer OutcomesXavier Paoletti, Damien Drubay, Laurence Collette
Contemporary Clinical Trials Communications|February 15, 2020
Proportional odds assumption for modeling longitudinal ordinal multiple toxicity outcomes in dose finding studies of targeted agents: A pooled analysis of 54 studiesDamien Drubay, Laurence Collette, Xavier Paoletti
Biostatistics (Oxford, England)|August 31, 2018
A benchmark for dose finding studies with continuous outcomesPavel Mozgunov, Thomas Jaki, Xavier Paoletti
Epidemiology (Cambridge, Mass.)|February 5, 2011
Sensitivity analysis when data are missing not-at-randomNoémie Resseguier, Roch Giorgi, Xavier Paoletti
Bulletin Du Cancer|August 7, 2016
[Not Available]Xavier Paoletti, Federico Rotolo, Stefan Michiels
Biometrical Journal. Biometrische Zeitschrift|June 13, 2020
Using a dose-finding benchmark to quantify the loss incurred by dichotomization in Phase II dose-ranging studiesPavel Mozgunov, Thomas Jaki, Xavier Paoletti
Biostatistics (Oxford, England)|August 23, 2003
Non-parametric optimal design in dose finding studiesJohn O'Quigley, Xavier Paoletti, Jean Maccario
Frontiers in Psychiatry|August 16, 2021
Reading, Conducting, and Developing Systematic Review and Individual Patient Data Meta-Analyses in Psychiatry for Treatment IssuesNadia Younes, Laurie-Anne Claude, Xavier Paoletti
European Journal of Cancer (Oxford, England : 1990)|November 21, 2018
Meta-analysis of prognostic and predictive factors: Towards individual participant data?Matthieu Faron, Jean-Pierre Pignon, Xavier Paoletti
Pageof 15